Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 469 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Therapeutic Community Clear all

Conditions: Hepatitis C
Interventions: Sofosbuvir and simeprevir; Drug
Lead sponsor: Arrowhead Regional Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Colton, California

Conditions: Childhood Obesity
Interventions: JOIN Intervention; Behavioral
Lead sponsor: UnitedHealth Group; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Dependence, Opioid
Interventions: Brief, values based intervention for early buprenorphine treatment; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Bedford, Massachusetts

Conditions: HIV Infections
Interventions: Corrections case management; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 784 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Chicago, Illinois

Conditions: Obesity, Childhood
Interventions: iChoose, Family Connections; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 5 Years to 12 Years
Enrollment: 267 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Alcohol Use Disorder, Harm Reduction, Housing First (eg. Permanent Supportive Housing)
Interventions: eHaRT-A; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 21 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Patient Engagement; Community Health Workers
Interventions: Community Health Worker Assessment; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: Not listed
Enrollment: 2,314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Covid19, Vaccine Refusal
Interventions: Community health worker engagement; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Temporomandibular Joint and Muscle Disorder
Interventions: Biobehavioral, Active Coping/Attention Intervention; Behavioral
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 18 Years and older
Enrollment: 456 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Suicide, Psychosis
Interventions: Cognitive Behavioral Suicide Prevention for psychosis CBSPp); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Psoriasis
Interventions: Clobetasol Propionate, 0.05%, Clobetasol propionate, 0.05% Spray; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 2,488 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Cedar Knolls, New Jersey

Conditions: Community Acquired Pneumonia
Interventions: Zabofloxacin, Levofloxacin 500mg, Zabofloxacin 400mg; Drug
Lead sponsor: IASO Pharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 13
States / cities: Huntsville, Alabama • Toney, Alabama • Fort Myers, Florida + 10 more

Conditions: Osteoporosis
Interventions: teriparatide; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 18
States / cities: Huntsville, Alabama • Montgomery, Alabama • Peoria, Arizona + 15 more

Conditions: Opioid Misuse
Interventions: Brief Intervention Medication Therapy Management, Standard Medication Counseling (SMC); Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Somerset, Pennsylvania

Conditions: Obesity, Physical Activity
Interventions: Exercise Prescription; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Warrensville Heights, Ohio

Conditions: Obesity
Interventions: Simulated insurance reimbursement; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 19 Years and older
Enrollment: 401 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: COVID-19, Trust
Interventions: Community-led discussion; Behavioral
Lead sponsor: Old Dominion University; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Cystic Fibrosis
Interventions: Nasal endoscopy with microbiome swab and mucus collection through filter paper and sponge, Olfactory Function Testing, Survey Completion; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Sinusitis, Bronchitis, Chronic, Pneumonia, Bacterial
Interventions: all macrolide antibiotics, all beta-lactam antibiotics; Drug
Lead sponsor: CPL Associates; Other
Eligibility: Up to 95 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Parkinson Disease
Interventions: Telehealth Exercise, speech therapy, medication management; Behavioral
Lead sponsor: University of Wyoming; Other
Eligibility: 30 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Las Vegas, Nevada • Laramie, Wyoming

Conditions: Anemia
Interventions: Standard of Care, Informational Series and follow-up support; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 21 Years to 55 Years · Female only
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Detroit, Michigan

Conditions: Aging Well, Dementia, Telemedicine
Interventions: Music Therapy Telehealth, Non-Collaborative Social Work Telehealth, Collaborative Social Work Telehealth; Behavioral
Lead sponsor: Alaine E Hernandez, PhD; Other
Eligibility: 65 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Lexington, Kentucky • St Louis, Missouri

Conditions: COVID-19 Testing Behaviors
Interventions: COVID-19 rapid test-to-treat, Standard COVID19 education control arm; Behavioral
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 18 Years to 120 Years
Enrollment: 900 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Covid-19, Critical Illness, Attitude of Health Personnel, Attitude to Health, Health Behavior, Health Care Utilization
Interventions: Brief educational video; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 1,971 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience

Community-based Program to Treat Childhood Obesity

A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment

Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for Illinois

A Trial of Two Family-based Childhood Obesity Treatment Programs

Electronic Harm Reduction Treatment for Alcohol

Using Rapid Cycle Trials to Increase Patient Engagement in the Community Health Worker Program in the Emergency Department

Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate

An Implementation and Biobehavioral Study of Temporomandibular Joint and Muscle Disorder (TMJMD)

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia

Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy

Community Pharmacists and Opioid Misuse

Bridging Resources Improve the Development of Guideline-based Exercise

Reimbursement Effects on Enrollment in Obesity Treatment

Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 1

Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome

Outcomes of Patients Not Responding to Antibiotics in the Community

Telehealth Allied Health Care With People Who Have Parkinson's Disease Living in Rural Nevada and Wyoming

Menstruation and Anemia Research: A Community Health Study

Music Therapy and Social Work Telehealth for Older Adult Well-Being

COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II)

Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19